C14orf166 抗体 (N-Term)
Quick Overview for C14orf166 抗体 (N-Term) (ABIN6742833)
抗原
See all C14orf166 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- Human C14orf166
-
预测反应
- Percent identity by BLAST analysis: Human, Horse, Xenopus (100%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide from N-Terminus of human C14orf166 (Q9Y224, NP_057123). Percent identity by BLAST analysis: Human, Chimpanzee, Orangutan, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Elephant, Panda, Dog, Bovine, Rabbit, Horse, Pig, Opossum, Guinea pig, Turkey, Zebra finch, Chicken, Platypus, Xenopus, Frog, Catfish, Salmon, Stickleback, Pike, Pufferfish, Zebrafish (100%), Sea squirt, Drosophila (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-Chromosome 14 Open Reading Frame 166 (C14orf166) antibody
C14orf166 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Chromosome 14 Open Reading Frame 166 (C14orf166) (AA 1-244) antibodyC14orf166 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Chromosome 14 Open Reading Frame 166 (C14orf166) (N-Term) antibodyC14orf166 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 兔, Pig WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Chromosome 14 Open Reading Frame 166 (C14orf166) (C-Term) antibodyC14orf166 适用: 人, 大鼠, Cow, 犬, 豚鼠, 马, 兔, Pig, 猴, 非洲爪蟾 WB 宿主: 兔 Polyclonal unconjugated
anti-Chromosome 14 Open Reading Frame 166 (C14orf166) (AA 85-134) antibodyC14orf166 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
